Lexeo Therapeutics, Inc. — All Filings
300 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001619 | Mar 27, 2026 | — |
| 4 | — | 0001995218-26-000006 | Mar 17, 2026 | Mar 13, 2026 |
| 4 | — | 0002024096-26-000007 | Mar 17, 2026 | Mar 13, 2026 |
| 4 | — | 0002024096-26-000005 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | — | 0001995218-26-000004 | Feb 20, 2026 | Feb 18, 2026 |
| 4/A | — | 0002024096-26-000004 | Feb 20, 2026 | Nov 18, 2025 |
| 144 | — | 0001959173-26-001161 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001152 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001143 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001141 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001140 | Feb 18, 2026 | — |
| 4 | — | 0002109299-26-000004 | Feb 17, 2026 | Feb 13, 2026 |
| SCHEDULE 13G/A | — | 0001104659-26-016498 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016355 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-052896 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001231919-26-000153 | Feb 13, 2026 | — |
| 4 | — | 0001995218-26-000002 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | — | 0002024096-26-000002 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | — | 0002083206-26-000002 | Feb 6, 2026 | Feb 4, 2026 |
| 3 | — | 0002109299-26-000002 | Feb 5, 2026 | Jan 20, 2026 |
| 8-K | 8-K | 0001193125-26-039425 | Feb 5, 2026 | Jan 30, 2026 |
| SCHEDULE 13G | — | 0000102909-26-000183 | Jan 30, 2026 | — |
| SCHEDULE 13G/A | — | 0001315863-26-000099 | Jan 29, 2026 | — |
| 8-K | 8-K | 0001193125-26-023339 | Jan 27, 2026 | — |
| SCHEDULE 13G | — | 0002012383-26-000688 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001193125-26-010091 | Jan 12, 2026 | — |
| EFFECT | — | 9999999995-25-003406 | Nov 26, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-300634 | Nov 26, 2025 | — |
| 4 | — | 0001995218-25-000007 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | — | 0001994972-25-000005 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | — | 0002009350-25-000005 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | — | 0001995009-25-000005 | Nov 20, 2025 | Nov 18, 2025 |
| 4 | — | 0002024096-25-000005 | Nov 20, 2025 | Nov 18, 2025 |
| SCHEDULE 13G | — | 0001104659-25-114635 | Nov 20, 2025 | — |
| 144 | — | 0001959173-25-007114 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007113 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007112 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007110 | Nov 18, 2025 | — |
| 144 | — | 0001959173-25-007105 | Nov 18, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-283019 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004978 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-281249 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-108535 | Nov 7, 2025 | — |
| S-3 | S-3 | 0001193125-25-265934 | Nov 5, 2025 | — |
| S-8 | S-8 | 0001193125-25-265784 | Nov 5, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-265757 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-265755 | Nov 5, 2025 | — |
| SCHEDULE 13G | — | 0001346824-25-000027 | Oct 27, 2025 | — |
| 4 | — | 0002009350-25-000003 | Oct 17, 2025 | Oct 15, 2025 |
| 4 | — | 0001995009-25-000003 | Oct 17, 2025 | Oct 15, 2025 |